<DOC>
	<DOCNO>NCT02544087</DOCNO>
	<brief_summary>The present study design confirm therapeutic effect heat-clearing blood-activating Chinese medicinal component treatment Acute Cerebral Infarction ( ACI ) investigate therapeutic mechanism multi-target anti-inflammatory action involve standpoint pathology , cell molecular biology , well immunology .</brief_summary>
	<brief_title>Heat-clearing Blood-activating Chinese Medicinal Components Acute Cerebral Infarction</brief_title>
	<detailed_description>The present study design confirm therapeutic effect heat-clearing blood-activating Chinese medicinal component treatment Acute Cerebral Infarction ( ACI ) investigate therapeutic mechanism multi-target anti-inflammatory action involve standpoint pathology , cell molecular biology , well immunology . In particular , investigator choose heat-clearing Ixeris sonchifolia Hance ( Kudiezi Injection ) blood-activating Panax notoginseng saponin ( Xueshuantong Injection ) therapeutic intervention carry investigation , apply key technique Lentivirus-mediated RNA interference , co-immunoprecipitation immunomagnetic bead . With joint effort , investigator hope find combined therapeutic target base well understanding inflammatory pathology ACI illuminate synergistic mechanism involve , may validate Chinese medicine theory '' cerebral vascular damage due heat toxicity '' pathogenesis ACI yield new therapeutic strategy ACI . As international science technology cooperation project , study great significance establish international technology platform intervention target system treatment ACI ; moreover , mark key step forward China enhance China 's international brand explore successful mode foreign cooperation Chinese medicine .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Patients acute ischemic stroke Patients fireheat syndrome Stroke onset within 48 hour NIHSS score range 5 point 25 point Age forty eighty , gender limit Informed sign consent Cardiogenic cerebral embolism , stroke cause reason unexplained Patients suitable thrombolytic therapy ( rtPA , urokinase ) , recieved thrombolytic therapy Patients suitable endovascular therapy , recieved endovascular therapy Patients serious disease heart , lung , liver kidneys（The value ALT AST 2 time upper limit normal range , value creatinine 1.5 time upper limit normal range，asthma COPD , cardiac function level 4） Patients bleed bleed tendency recently Pregnant lactate woman Preexisting limb dysfunction , psychiatric diaseses，or cognitive dysfunction could confound study result Patients allergic constitution , contraindication Ixeris sonchifolia Hance component ( KDZ injection ) Panax notoginseng saponins component ( Xueshuantong injection ) Patients participate clinical trial within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>fire-heat syndrome</keyword>
	<keyword>blood stasis syndrome</keyword>
	<keyword>method clearing heat</keyword>
	<keyword>method promote blood circulation</keyword>
</DOC>